Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

Size: px
Start display at page:

Download "Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs"

Transcription

1 Changing the Tide An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs Ken Hahlweg MD, CCFP, FCFP Assistant Professor Department of Family Medicine

2 Conflicts of Interest I d rather be gardening! Otherwise, no conflict of interest to declare

3 Objectives Discuss the challenges inherent in prescribing and de-prescribing controlled drugs Identify system gaps that perpetuate prescribing angst and misadventure Present an EMR facilitated clinic process that is both patient-centred and prescriber friendly

4 The Encounter Fraught with Dilemmas Is there a clinical indication or not? Is there patient benefit or harm? Am I being fair or am I biased? Do I take a hard line and if I do, will the patient come back? Is the patient being honest or is there a hidden agenda? Am I supporting or undermining my colleague s practice? How can I achieve common ground and maintain my integrity as a care provider? Am I doing the right thing?

5 Shared decision making Patient s ideas Common Ground Physician s ideas

6 Patient Ideas Shared Relieves pain Relieves anxiety Manages sleep Improves quality of life Improves functioning Impairs memory Impairs sleep Impairs sexual functioning Constipation Withdrawal symptoms Fear of dependency or addiction Tolerance

7 Patient Ideas Not Shared Source of income Means to obtain drug of choice Method of coping

8 Prescriber Ideas Shared Indication Appropriateness Effectiveness Harms vs Benefits Therapeutic relationship built on trust Prescriber responsibilities Patient responsibilities

9 Prescriber Ideas Not Shared Is the patient being honest Substance misuse and abuse suspicion Suspicion of diversion and community harm Is the patient s interpretation of benefit coloured by drug dependence Is the patient splitting and/or manipulating

10 Shared decision making Patient s ideas Appropriate Safe Effective Physician s ideas

11 System supports for prescribing controlled drugs 2017 Guidelines (NOUGG- National Opiate Use Guideline Group) Opiate Risk Assessment tool Continuing Medical Education Manitoba Prescribing Practices Program (M3P) E-chart Opiate contract templates and management tools Ashton Manual (benzo.org.uk) Comprehensive urine drug testing

12 System gaps for prescribing controlled drugs Patients who are chronic users of opiates, benzos and other controlled substances are seen as undesirable patients and have difficulty finding a primary care provider that will accept them Tools to support safe and effective prescribing of controlled substances generally directed at the individual prescriber Few system supports exist for practice groups prescribing to defined practice population Frustration exists when patients transition between care providers both within and without practice groups

13 Northern Connection Medical Centre Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Patient s ideas Opiate/Benzo Plan Physician s ideas

14 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Definitions: This policy is a voluntary binding agreement between the physicians of NCMC. Acute is defined as less than two weeks and as a distinct occasion Chronic is defined as anything other than acute A Plan refers to a chronic opiate and benzodiazepine prescribing plan made by the patient s primary (most responsible) clinic physician. A prescribing contract refers to an agreement by the patient to limit his/her behaviour(s) in specific ways.

15 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Accepted indications for prescribing: Harm reduction for dependent users Tapering down/off for therapeutic purposes (either no or a soft indication for prescribing, dependency, tolerance, cognitive side effects, risk for falling etc.) Therapy for chronic pain and/or mental health diagnoses in selected patients.

16 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 1. All patients being prescribed more than two weeks worth of any opioid or benzodiazepine in one year should have a Plan documented by their prescribing primary care provider. 2. The existence of a Plan should be documented in free text with the words opiate plan or benzo plan under the indication diagnosis in the Problem List (History of Problems). If more than one indication exists, the existence of the plan should be documented for both diagnoses eg chronic pain syndrome AND opiate dependence.

17 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 3. The Plan itself should be documented in the Encounter Notes, labeled as opiate plan or benzo plan, and the note should be linked to the primary indication diagnosis in the Problem List. 4. When the Plan is updated or superseded by a new Plan this should be documented in a new note in the Encounter Notes. This updated Plan should also be labeled as opiate plan or benzo plan, and the note should be linked to the primary indication diagnosis in the Problem List. The most recent Plan can be found by selecting the indication diagnosis from the Problem List and identifying the most recent version.

18 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 5. Only the primary (most responsible) physician should initiate chronic prescribing. Any other prescriber should limit their prescription to less than two weeks and require follow-up with the primary physician rather than extending use beyond two weeks. 6. The primary physician is responsible to review the Plan and update documentation at least yearly.

19 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 7. The Plan should at a minimum communicate the following: a. Whether the Plan is: a mandatory taper (hard taper) a taper as tolerated by the patient (soft taper) a maintenance plan at the same dose a plan for titration to clinical effect (including the option of increasing the dose) or a plan for no prescribing except for acute use under exceptional circumstances. b. The timeframe for the plan should be documented if it is other than one year.

20 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 8. Optional elements of the Plan include: Medication prescription intervals (before a new visit is required) Medication dispensing intervals Regular urine drug screens and frequency thereof A prescribing contract

21 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 9. If other care providers note that any of the expectations of this policy are not being met they are to send a task to the primary physician alerting them to this fact and requesting that this be addressed 10. No physician is required to prescribe a medication that they feel is unsafe for the patient or the community under any circumstances

22 NCMC Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Expectations of Care Providers: 11. If other caregivers have concerns about the Plan potentially harming the patient or others they are to communicate their concerns to the primary physician 12. Other caregivers are expected to support the Plan as long as they feel it is safe. This may include prescribing within the limits of the Plan, or making an interim Plan until the Plan can be reassessed by the primary physician

23 Applying the NCMC Policy on Chronic Opiate and Benzodiazepine Prescribing Task your colleague if: No plan Concerns about plan appropriateness Lack of clarity to plan Plan out of date

24 Applying the NCMC Policy on Chronic Opiate and Benzodiazepine Prescribing The patient without a plan Options for colleagues: Make an interim plan Refuse to prescribe at all Prescribe for a short period bridging the patient to a visit with their primary health care provider

25 Northern Connection Medical Centre Consensus Policy on Chronic Opiate and Benzodiazepine Prescribing Patient s ideas Opiate/Benzo Plan Physician s ideas

26 Objectives Discuss the challenges inherent in prescribing and de-prescribing controlled drugs Identify system gaps that perpetuate prescribing angst and misadventure Present an EMR facilitated clinic process that is both patient-centred and prescriber friendly

27

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Preamble This Standard establishes the standards of practice and ethical requirements of all physicians

More information

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use Effective Date: May 19, 2008 Revised Date: August 18, 2015 Approved by: Thomas M Tocher, MD, MPH, Chief Clinical Officer Policy Number: MED Policy 313 Title: Pain Management Long Term Opioid Use POLICY

More information

Controlled Substance and Wellness Agreement

Controlled Substance and Wellness Agreement Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)

More information

Ahsan U. Rashid, M.D., F.A.C.P.

Ahsan U. Rashid, M.D., F.A.C.P. Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program

More information

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management Quality Improvement Support: Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management The Aims and Measures section is intended to provide protocol users with a menu of measures for multiple

More information

Welcome to The Woodlands Great Oaks Tall Trees

Welcome to The Woodlands Great Oaks Tall Trees Welcome to The Woodlands The Woodlands provides a welcoming and friendly environment for services users, families and carers. It is a purpose built facility with a unique contemporary design. The Woodlands

More information

Clinical contracts. Dr. Johan Wouterloot Prescribers Course April 28, 2017

Clinical contracts. Dr. Johan Wouterloot Prescribers Course April 28, 2017 Clinical contracts Dr. Johan Wouterloot Prescribers Course April 28, 2017 Why? Ameliorates power imbalance States a goal for the agreed upon activity Allows for contingency management to keep behaviour

More information

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Recommendations in Opioid Prescribing Guidelines for Chronic Pain Recommendations in Opioid Prescribing Guidelines for Chronic Pain The use of opioids for treating chronic pain has been increasing. 1 In 2010, an estimated 20% of patients presenting to physician offices

More information

Dr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei

Dr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei Dr Alistair Dunn Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei 8:30-9:25 WS #147: The Bottom Line; Tackling the Problem of Prescribed Drug Addiction 9:35-10:30

More information

Pain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018

Pain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018 Pain, Opioids and the EMR Dr. Gordon Schacter April 12, 2018 Faculty/Presenter Disclosure Faculty: Gordon Schacter Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria:

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient Approaches to Responsible Opioid Prescribing The Opioid Naïve Patient Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

MEDICATION MANAGEMENT AGREEMENT

MEDICATION MANAGEMENT AGREEMENT MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The

More information

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and

More information

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: All patients 18 and older

More information

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses Identifying and Preventing Drug Abuse By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Medical vs. Non-Medical Use of Drugs Intent Effect

More information

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE TO: FROM: SUBJECT: All Part D Sponsors Amy Larrick

More information

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this? Oregon ACEP Opioid Prescribing Guidelines Hans Notenboom, M.D. FACEP Current OCEP President Why are we talking about this? Current opioid epidemic 33,000 deaths over half with Rx meds Since 1999 number

More information

Data Driven Strategies

Data Driven Strategies Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words

More information

Methadone Diversion: Why it happens, what the illicit market looks like and the implications

Methadone Diversion: Why it happens, what the illicit market looks like and the implications Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University Methadone provision and

More information

The Difficult Patient: Risk Mitigation Strategies

The Difficult Patient: Risk Mitigation Strategies The Difficult Patient: Risk Mitigation Strategies C. Scott Anthony, D.O. Pain Management of Tulsa 1 Opioid Backlash National emergency Opioids not indicated for chronic pain Forces pushing for reduction

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA Department of Veterans Affairs Network Policy No.: 2014-01 VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA CHRONIC OPIOID USE FOR NON-MALIGNANT PAIN 1. PURPOSE: To

More information

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,

More information

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR Practical Tools to Successfully Taper Prescription Opioids Melissa Weimer, DO, MCR Objectives Understand how to calculate morphine equivalents per day Understand the steps necessary to plan a successful

More information

Use of Opioids for Chronic Non Malignant Pain (CNMP)

Use of Opioids for Chronic Non Malignant Pain (CNMP) I. PURPOSE Use of Opioids for Chronic Non Malignant Pain (CNMP) We the Safe Opioid Prescribing and Review Committee (SOPARC) are inspired to support a shift in opioid prescribing that improves clinical

More information

Behavioral Health in PACE: Substance Abuse

Behavioral Health in PACE: Substance Abuse Behavioral Health in PACE: Substance Abuse NPA s Quality Symposium 2017 June 9th, 2017 Bharati Srivastava MD MBA FACP AGSF Mercy LIFE Sharon Hill Mercy LIFE Southeastern PA Trinity Health Inc. Objectives

More information

Proposed Revision to Med (i)

Proposed Revision to Med (i) Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and

More information

Xanax dosage for alcohol withdrawal

Xanax dosage for alcohol withdrawal I've also talked to my doctor, who had previously prescribed me alprazolam ( Xanax), when I was trying to pass my alcoholism off as an anxiety disorder. Anyway, my doctor told me that I could continue

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998 KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION Naltrexone is used as part of a comprehensive programme of treatment against alcoholism to reduce the

More information

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Ken Whittemore, Jr. R.Ph., MBA Senior VP, Professional & Regulatory Affairs Copyright Copyright 2015 by 2015 Surescripts,

More information

Tapering off ativan.5

Tapering off ativan.5 Tapering off ativan.5 Search 10-3-2012 Home Q & A Questions Anxiety - Properly tapering. Anxiety - Properly tapering off Ativan?. I have been on.5 mg ativan for about 3 weeks. Ativan Withdrawal and Detox..

More information

Prescription Monitoring Program (PMP)

Prescription Monitoring Program (PMP) 06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid

More information

NBPDP Drug Utilization Review Process Update

NBPDP Drug Utilization Review Process Update Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

OPIOID PAIN MEDICATION Agreement and Informed Consent

OPIOID PAIN MEDICATION Agreement and Informed Consent OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The

More information

Overview of Opiate Addiction

Overview of Opiate Addiction Overview of Opiate Addiction Conflict of interest 2 talks for Purdue about dangers of opioid addiction Bias support patients in both abstinence and methadone but seeing more stability on MMT Opioid Addiction

More information

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Safe Prescribing of Drugs with Potential for Misuse/Diversion College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines

More information

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic

More information

Addressing the Opioid Epidemic in the Veterans Health Administration

Addressing the Opioid Epidemic in the Veterans Health Administration Addressing the Opioid Epidemic in the Veterans Health Administration Julie Gochnour, MD Governor s Working Group on Veterans, Service Members, and Their Families May 25, 2017 Overview Epidemiology of the

More information

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW) Dr. Paul A. Farnan farnan@mail.ubc.ca HealthQuest Occupational Health Corporation Alliance Medical Monitoring I have no financial interests or affiliation with any pharmaceutical industry or manufacturer

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 December 2007

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 December 2007 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 December 2007 METHADONE AP-HP 1mg, gelatin-coated capsule Box of 7 (CIP: 379 146-2) METHADONE AP-HP 5mg, gelatin-coated

More information

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / / COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION Name Birthdate / / Home phone ( ) - Cell phone ( ) - Please answer the following questions which will help

More information

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R)

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R) is a tool for clinicians to help determine how much

More information

NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification

NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) Rationale General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification Aims It is the responsibility of general practitioners

More information

Triage, Assessment and Treatment Planning

Triage, Assessment and Treatment Planning Triage, Assessment and Treatment Planning Prepared by Todd Sakakibara MD, CCFP, FCFP Clinical Assistant Professor, Dept. Family Practice UBC Diplomate of the American Board of Addiction Medicine Triage

More information

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing Strategies in Managing Opioid and Benzodiazepine Co-Prescribing Scott Endsley, MD Associate Medical Director, Quality Partnership HealthPlan of California October 25, 2016 Audio Instructions To avoid echoes

More information

Chronic Pain Management in the Primary Care Setting

Chronic Pain Management in the Primary Care Setting Chronic Pain Management in the Primary Care Setting Keeping you and your patients safe. Joel Porter, MD October 1, 2015 Chronic Pain Management Chronic pain is a major public health problem Existing chronic

More information

Prescription Opioid Addiction

Prescription Opioid Addiction CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett

More information

How long does.5 mg xanax stay in your system

How long does.5 mg xanax stay in your system Search Search How long does.5 mg xanax stay in your system Xanax half life: how long does Xanax stay in your system.. Xanax half life: how long does Xanax now I m recommending Xanax. 5 mg to help her relax.

More information

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal.

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal. Six Building Blocks Self-Assessment The purpose of the self-assessment is to initiate a discussion among the opioid improvement team (or all members of your clinic) about the current state of your organization

More information

Opioids and Chronic Pain: Case studies and Personal Experience

Opioids and Chronic Pain: Case studies and Personal Experience Opioids and Chronic Pain: Case studies and Personal Experience Dr Rupa Patel, MD, CCFP, FCFP Assistant Professor, Department of Family Medicine, Queen s University Kingston Community Health Center Faculty/Presenter

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

how long does tramadol withdrawal last?? i was on tramadol for about 2 weeks and this is my third day without tramadol you think how much

how long does tramadol withdrawal last?? i was on tramadol for about 2 weeks and this is my third day without tramadol you think how much 18-10-2014 how long does last?? i was on tramadol for about 2 weeks and this is my third day without tramadol you think how much time left to. At the same how long does last,. How long does last from tramadol.

More information

Principles and language suggestions for talking with patients

Principles and language suggestions for talking with patients SAFER MANAGEMENT OF OPIOIDS FOR CHRONIC PAIN: Principles and language suggestions for talking with patients Use these principles and language suggestions when discussing opioid risks and safety monitoring

More information

Management of Chronic Non Cancer Pain Tool Instruction Manual for Practice Solutions Electronic Medical Record Intended Tool Use

Management of Chronic Non Cancer Pain Tool Instruction Manual for Practice Solutions Electronic Medical Record Intended Tool Use Management of Chronic Non Cancer Pain Tool Instruction Manual for Practice Solutions Electronic Medical Record Intended Tool Use Clinical best practices and recommendations that follow the Centre for Effective

More information

Test User got 22 of 22 possible points on the Risk Reduction Strategies for ER/LA Opioids Post-Test. Total score: 100 %

Test User got 22 of 22 possible points on the Risk Reduction Strategies for ER/LA Opioids Post-Test. Total score: 100 % Published on OpioidRisk (https://www.opioidrisk.com) Home > Results Test User got 22 of 22 possible points on the Risk Reduction Strategies for ER/LA Opioids Post-Test. Total score: 100 % Question Results

More information

Applying Universal Precautions to Chronic Opioid Therapy 5P s Assessment

Applying Universal Precautions to Chronic Opioid Therapy 5P s Assessment Elements of Leverage Point #3: Applying Universal Precautions to Chronic Opioid Therapy 1. Diagnosis with reasonable differential 2. Psychological assessment including risk of addictive disorders Purpose

More information

An introduction to providing trauma informed services

An introduction to providing trauma informed services An introduction to providing trauma informed services TIC - for volunteers 1. Why this presentation 2. Trauma, neglect and attachment 3. Working in a trauma informed way as a volunteer 4. Looking after

More information

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G

More information

Methadone Maintenance 101

Methadone Maintenance 101 Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms

More information

Legal Issues in Opioid Prescribing

Legal Issues in Opioid Prescribing Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not

More information

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the nausea and. wisdom in this exchange. Alprazolam, available

More information

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018

More information

1. Comprehensive assessment undertaken prior to initiating an opioid (Pain assessment as per UCLH history taking Performa)

1. Comprehensive assessment undertaken prior to initiating an opioid (Pain assessment as per UCLH history taking Performa) OPIOID TRACKER CARD Name DOB Sex Hospital Number Diagnosis FOR NEW PRESCRIPTIONS OPIOID PRESCRIPTION CHECKLIST 1. Comprehensive assessment undertaken prior to initiating an opioid (Pain assessment as per

More information

Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of Toronto

Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of Toronto Team Based Approaches to Chronic Pain Management: Opioid Stewardship Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of

More information

Addiction vs. Dependence. Introduction. Methadone: Historical Background. Addiction vs. Dependence. C.O.R.E. Medical Clinic, Inc.

Addiction vs. Dependence. Introduction. Methadone: Historical Background. Addiction vs. Dependence. C.O.R.E. Medical Clinic, Inc. C.O.R.E. Medical Clinic, Inc. Chapter I Opioids and the Brain 2 Chapter Overview Introduction Addiction vs. Dependence Methadone: Historical Background Brain Chemistry: Before & After Opiate Use Methadone

More information

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Implementing Pain and Opioid Management Guidelines in Primary Care Practice Implementing Pain and Opioid Management Guidelines in Primary Care Practice Objectives 1. What is the issue? 2. Why use a dedicated dissemination & implementation process? a. Historical perspective Cooperative

More information

Section I. Short-acting opioid Prior Authorization Criteria

Section I. Short-acting opioid Prior Authorization Criteria Request for Prior Authorization for Opioid analgesics Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 Requests for opioid analgesics may be subject to prior authorization

More information

Patient and Family Agreement on Opioids

Patient and Family Agreement on Opioids Patient and Family Agreement on Opioids We care about our patients and are committed to their recovery and wellness. We offer our patients medications and options for various services to keep them from

More information

Appendix F Federation of State Medical Boards

Appendix F Federation of State Medical Boards Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction

More information

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19 Clinical Policy: Reference Number: CP.PMN.97 Effective Date: 02.11 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory

More information

SMMGP SPECIAL INTEREST TRAINING DAY

SMMGP SPECIAL INTEREST TRAINING DAY SMMGP SPECIAL INTEREST TRAINING DAY Problematic use of over-the-counter (OTC) medication: prevalence, evidence and how to manage people with these problems Wednesday 11 th May 2011 Chris Ford SMMGP Clinical

More information

Controlled Substances: A survey of tools and resources required by hospital pharmacists

Controlled Substances: A survey of tools and resources required by hospital pharmacists Controlled Substances: A survey of tools and resources required by hospital pharmacists TABLE OF CONTENTS 2018. Canadian Society of Hospital Pharmacists About the survey 1 The Short and Snappy 1 What CSHP

More information

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Presented by Scott Levy M.D. M.P.H. FACOEM Assistant Regional Medical Director, Occupational Health Services The Permanente Medical Group

More information

The Challenges of Opioid Prescribing in Family Practice. Dr. Stephen Barron Prescribers Course May 13, 2016

The Challenges of Opioid Prescribing in Family Practice. Dr. Stephen Barron Prescribers Course May 13, 2016 The Challenges of Opioid Prescribing in Family Practice Dr. Stephen Barron Prescribers Course May 13, 2016 Know your patients Low Addiction Risk High Addiction Risk Easier Harder Chronic Pain Pathology

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services FOLLOW DIRECTIONS How to Use Methadone Safely U.S. Department of Health & Human Services Substance Abuse and Mental Health Services Administration Food and Drug Administration Methadone Methadone provides

More information

2017 Opioid Guideline Update

2017 Opioid Guideline Update 2017 Opioid Guideline Update The 2017 Canadian Guideline for Opioid Therapy and Chronic Non-Cancer Pain (CNCP) Dr. Lydia Hatcher, MD, CCFP, FCFP, CHE, D-CAPM Associate Clinical Professor of Family Medicine,

More information

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid OPIOIDS Questions about opioids, and the Answers that may SURPRISE YOU A booklet for people who may benefit from reducing or stopping their opioid Generic Name morphine hydromorphone oxycodone tramadol

More information

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid OPIOIDS Questions about opioids, and the Answers that may SURPRISE YOU A booklet for people who may benefit from reducing or stopping their opioid Generic Name morphine hydromorphone oxycodone tramadol

More information

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

ISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.

ISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners. Code of New Mexico Rules Title 16. Occupational and Professional Licensing Chapter 17. Osteopathic Medicine and Surgery Practitioners Part 5. Prescribing and Distribution of Controlled Substances 16.17.5.

More information

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,

More information

Home Mailing list Search Browse Hot topics Matrices About Help Contact

Home Mailing list Search Browse Hot topics Matrices About Help Contact 1 of 5 https://findings.org.uk/php/dl.php?f=nosyk_b... 08/11/18 12:11 Home Mailing list Search Browse Hot topics Matrices About Help Contact Send email for updates SEND About updates This entry is our

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

Policy for Substance Misuse and Substance Misuse Testing

Policy for Substance Misuse and Substance Misuse Testing Policy for Substance Misuse and Substance Misuse Testing 1. Introduction Given a national backdrop of increasing drug and other substance misuse among teenagers, including alcohol, we wish to ensure that

More information

Mini Lecture Week 14 VALUES ETHICS

Mini Lecture Week 14 VALUES ETHICS Mini Lecture Week 14 VALUES ETHICS Would you read this book in your classroom? What are values? Values are things that we believe are intrinsically worthwhile or desirable for their own merit (e.g. freedom

More information

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond David Anisman, MD Medical Director, Farmington Health Center (Primary Care) Associate Medical Director, Community

More information

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017 SAFE PRESCRIBING: RULES AND REGULATIONS Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017 DISCLOSURES I have no financial disclosures. OBJECTIVES Discuss the significance of the opiate

More information

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014 Maintaining Patient Safety When Chronic Opioid Therapy Is Prescribed P. David Pacheco, Ph.C, PA-C, CAAAPM Pain Medication Management Specialist Southwest Interventional Pain Specialists, PC 4700 Jefferson

More information